ASSOCIATION BETWEEN SPECIFIC FEATURES OF GATA3 TRANSCRIPTION FACTOR EXPRESSION AND LYMPH NODE METASTASIS IN LUMINAL BREAST CANCER

ASSOCIATION BETWEEN SPECIFIC FEATURES OF GATA3 TRANSCRIPTION FACTOR EXPRESSION AND LYMPH NODE METASTASIS IN LUMINAL BREAST CANCER

Currently, the study of the markers of cell differentiation, proliferative regulators, and molecules involved in the development of drug resistance mechanisms in breast cancer is extremely important. The transcription factor GATA3 plays an essential role in the differentiation and proliferative acti...

Full description

Bibliographic Details
Main Authors:	S. V. Vtorushin, D. V. Vasilchenko, К. Y. Khristenko, N. V. Krakhmal, I. V. Stepanov, М. V. Zavyalova, E. M. Slonimskaya, S. V. Patalyak
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2017-11-01
Series:	Сибирский онкологический журнал
Subjects:	рак молочной железы транскрипционный фактор gata3 лимфогенное метастазирование прогноз лекарственная устойчивость
Online Access:	https://www.siboncoj.ru/jour/article/view/612

Similar Items

MORPHOLOGICAL STUDY OF LUMINAL BREAST CANCER
by: M. V. Zavyalova, et al.
Published: (2016-02-01)

LYMPHOGENIC METASTASIS IN LUMINAL-TYPE A BREASR CANCER
by: M. V. Zavjalova, et al.
Published: (2016-02-01)

FEATURES OF BILATERAL BREAST CANCER NODAL METASTASIS
by: Ye. A. Fesik, et al.
Published: (2014-12-01)

Studying GATA3, FOXA1, and ELF5 transcription factors in the evaluation of prognosis in luminal breast cancer patients
by: S. V. Vtorushin, et al.
Published: (2021-01-01)

Chymotrypsin-like and caspase-like proteasome activities in breast cancer
by: E. E. Shashova, et al.
Published: (2016-02-01)

RELATIONSHIP BETWEEN THE EXPRESSION OF ERG/ PBOV1 PROTEINS AND LYMPH NODE METASTASIS AND MORPHOLOGICAL CHARACTERISTICS OF ACINAR ADENOCARCINOMA OF THE PROSTATE
by: N. V. Bezgodova, et al.
Published: (2017-07-01)

COMMUNICATION OF HEMATOGENOUS DISSEMINATION FROM LYMPH NODE METASTASIS FOR DIFFERENT MOLECULAR-GENETIC VARIANTS OF BREAST CANCER
by: N. S. Telegina, et al.
Published: (2013-12-01)

A LINK BETWEEN AUTOPHAGY REGULATORY PROTEINS M-TOR AND BECLIN-1 AND PARAMETERS OF LYMPHOGENIC METASTASIS IN COLORECTAL CANCER
by: S. V. Vtorushin, et al.
Published: (2018-09-01)

EGFR EXPRESSION IN RECTAL CANCER, RELATION TO THE FREAQUENCY OF LYMPH NODE METASTASIS
by: I. V. Stepanov, et al.
Published: (2017-06-01)

LIMCH1 protein expression associated with lymph node metastasis in breast cancer
by: V. V. Alifanov, et al.
Published: (2023-02-01)

The features of tumor niche cell composition in invasive breast ductal carcinoma of no special type
by: A. V. Buzenkova, et al.
Published: (2022-11-01)

Role of proteasome system in prognosis of breast cancer progression
by: E. E. Shashova, et al.
Published: (2018-09-01)

Clinical, morphological, and molecular genetic predictors of metastatic lesions in the regional lymph nodes in breast cancer
by: Yu. A. Dergunova, et al.
Published: (2018-11-01)

THE ROLE OF GATA3, FOXA1, ELF5 TRANSCRIPTION FACTORS IN THE PATHOGENESIS AND PROGNOSIS OF BREAST CANCER
by: D. V. Vasilchenko, et al.
Published: (2020-07-01)

MODERN VIEWS ON BILATERAL BREAST CANCER
by: Ye. A. Fesik, et al.
Published: (2014-10-01)

The influence of functional skewness on prognosis of cancer of mammary gland
by: L. E. Erendeeva, et al.
Published: (2002-03-01)

RELATIONSHIP BETWEEN PARAMETERS OF TUMOR NEOANGIOGENESIS AND LYMPHOGENOUS METASTASIS IN PATIENTS WITH RECTAL CANCER
by: I. V. Stepanov, et al.
Published: (2017-07-01)

CLINICAL PERSPECTIVES FOR STUDYING THE NUCLEAR TRANSCRIPTION FACTOR NF-κB IN BREAST CANCER
by: E. S. Gershtein, et al.
Published: (2014-09-01)

TRIM16 transcription factor in prostate cancer
by: L. V. Spirina, et al.
Published: (2018-09-01)

Predicting the site of distant metastases in breast cancer
by: E. S. Grigoryeva, et al.
Published: (2023-02-01)

HETEROGENENOUS EXPRESSION OF MARKERS ASSOCIATED WITN INVASIVE BREAST CANCER
by: N. V. Krakhmal, et al.
Published: (2016-10-01)

STUDY OF THE RELATIONSHIP BETWEEN CIRCADIAN RHYTHMS AND DRUG RESISTANCE OF BREAST TUMOR CELL LINES
by: A. M. Оgloblina, et al.
Published: (2015-12-01)

CORRELATION BETWEEN CHEMOTHERAPY RESPONSE AND EXPRESSION PROFILES OF TRANSMEMBRANE PROTEINS: P-GLYCOPROTEIN (ABCB1), MRP2 (ABCC2), BCRP (ABCG2) IN PATIENTS WITH INVASIVE BREAST CANCER
by: К. Yu. Khristenko, et al.
Published: (2016-10-01)

THE LONG-TERM RESULTS OF OCCULT BREAST CARCINOMA TREATMENT
by: T. V. Kuklenko
Published: (2017-01-01)

THE INFLAMMATORY STATUS AND LYMPH NODE METASTASES IN NON-SMALL CELL LUNG CANCER
by: D. S. Pismenny, et al.
Published: (2020-07-01)

ROR1 and BMI-1 proteins as potential predictors of the effectiveness of hormone therapy in luminal breast cancer
by: V. O. Tarakanova, et al.
Published: (2022-06-01)

RELATIONSHIP BETWEEN EXPRESSION OF MATRIX METALLOPROTEINASES AND MORPHOLOGICAL HETEROGENEITY, TUMOR DIFFERENTIATION AND LYMPHOGENOUS METASTASIS OF SQUAMOUS CELL LARYNGEAL CARCINOMA
by: О. V. Savenkova, et al.
Published: (2016-02-01)

ASSOCIATION OF THE COMBINATION OF STEMNESS GENE AMPLIFICATIONS AND COPY NUMBER ABERRATIONS OF WNT-SIGNALING GENES IN BREAST TUMORS WITH METASTASIS
by: N. V. Litviakov, et al.
Published: (2020-07-01)

LONG-TERM PROGNOSIS IN PATIENTS WITH A LOCAL BREAST CANCER RELAPSE AFTER ORGAN-SAVING TREATMENT
by: V. A. Uimanov, et al.
Published: (2014-09-01)

INDUCED BREAST CANCER IN A MAN WITH MULTIPLE PRIMARY CANCER (A CASE REPORT)
by: А. D. Kaprin, et al.
Published: (2016-02-01)

TRANSCRIPTION FACTOR BRN-3α AND PROSTATE CANCER, RELATION WITH HORMONE RECEPTORS AND AKT/M-TOR SIGNALING PATHWAY ACTIVATION
by: L. V. Spirina, et al.
Published: (2018-03-01)

PREGNANCY IN WOMEN WITH A HISTORY OF BREAST CANCER
by: A. A. Parokonnaya, et al.
Published: (2014-09-01)

ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE
by: N. N. Babyshkina, et al.
Published: (2017-06-01)

MOLECULAR MARKERS ASSOCIATED WITH THE RESPONSE TO THERAPY WITH EVEROLIMUS IN PATIENTS WITH RENAL CELL CARCINOMA
by: Z. А. Yurmazov, et al.
Published: (2016-07-01)

Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom
by: L G Zhukova, et al.
Published: (2009-09-01)

SURGICAL OUTCOMES IN PATIENTS WITH PROXIMAL GASTRIC CANCER WITHOUT ESOPHAGEAL INVASION
by: F. Sh. Akhmetzyanov, et al.
Published: (2021-08-01)

LOBE-SPECIFIC METASTASIS IN NON-SMALL CELL LUNG CANCER
by: A. A. Aksarin, et al.
Published: (2021-10-01)

THE ROLE OF GROWTH AND TRANSCRIPTION FACTORS IN EVALUATING THE EFFECTIVENESS OF NEOADYUVANTNOY CHEMOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
by: E. A. Usynin, et al.
Published: (2016-12-01)

IMAGING TECHNIQUES FOR THE DETECTION OF LYMPH NODE METASTASIS IN PATIENTS WITH LARYNGEAL ANF HYPOPHARYNGEAL CANCER
by: I. G. Frolova, et al.
Published: (2018-07-01)

ЛАТЕРАЛЬНОЕ МЕТАСТАЗИРОВАНИЕ ПРИ РАКЕ ПРЯМОЙ КИШКИ
Published: (2015-06-01)